Literature DB >> 19501388

Clinical and laboratory factors associated with shear-dependent platelet hyper-reactivity in patients on chronic aspirin therapy.

Susanna M Nazarian1, Jason B Thompson, Tyler J Gluckman, Katherine Laws, Jayesh T Jani, Thomas S Kickler, Jeffrey J Rade.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19501388      PMCID： PMC2975867          DOI： 10.1016/j.thromres.2009.04.016

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  19 in total

Review 1.  Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction.

Authors:  B Jilma
Journal:  J Lab Clin Med       Date:  2001-09

Review 2.  Clinical application of the PFA-100.

Authors:  Emmanuel J Favaloro
Journal:  Curr Opin Hematol       Date:  2002-09       Impact factor: 3.284

3.  Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals.

Authors:  Hannelore Haubelt; Christof Anders; Anette Vogt; Petra Hoerdt; Ulrich Theo Seyfert; Peter Hellstern
Journal:  Br J Haematol       Date:  2005-09       Impact factor: 6.998

4.  Platelet function analysis with PFA-100 in patients medicated with acetylsalicylic acid strongly depends on concentration of sodium citrate used for anticoagulation of blood sample.

Authors:  K W von Pape; E Aland; J Bohner
Journal:  Thromb Res       Date:  2000-05-15       Impact factor: 3.944

5.  Comparison of four commercial citrate blood collection systems for platelet function analysis by the PFA-100 system.

Authors:  E J Heilmann; S K Kundu; R Sio; C Garcia; R Gomez; D J Christie
Journal:  Thromb Res       Date:  1997-07-01       Impact factor: 3.944

6.  Impaired platelet function among platelet donors.

Authors:  P Jilma-Stohlawetz; N Hergovich; M Homoncik; L Dzirlo; M Horvath; M Janisiw; S Panzer; B Jilma
Journal:  Thromb Haemost       Date:  2001-09       Impact factor: 5.249

7.  Platelet function predicts myocardial damage in patients with acute myocardial infarction.

Authors:  Martin Frossard; Ingrid Fuchs; Judith M Leitner; Kety Hsieh; Marianne Vlcek; Heidrun Losert; Hans Domanovits; Wolfgang Schreiber; Anton N Laggner; Bernd Jilma
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

8.  In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor.

Authors:  Tahar Chakroun; Grigoris Gerotziafas; Françoise Robert; Chantal Lecrubier; Meyer Michel Samama; Mohamed Hatmi; Ismail Elalamy
Journal:  Br J Haematol       Date:  2004-01       Impact factor: 6.998

9.  Effect of calcium ion concentration on the ability of fibrinogen and von Willebrand factor to support the ADP-induced aggregation of human platelets.

Authors:  E J Harfenist; M A Packham; R L Kinlough-Rathbone; M Cattaneo; J F Mustard
Journal:  Blood       Date:  1987-09       Impact factor: 22.113

10.  Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery.

Authors:  T J Gluckman; J B Segal; S P Schulman; E P Shapiro; T S Kickler; M M Prechel; J V Conte; J M Walenga; I Shafique; J J Rade
Journal:  J Thromb Haemost       Date:  2009-06-23       Impact factor: 5.824
View more
  4 in total

1.  Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery.

Authors:  Tyler J Gluckman; Rhondalyn C McLean; Steven P Schulman; Thomas S Kickler; Edward P Shapiro; John V Conte; Kathleen W McNicholas; Jodi B Segal; Jeffrey J Rade
Journal:  J Am Coll Cardiol       Date:  2011-03-01       Impact factor: 24.094

2.  Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk.

Authors:  M T Olson; T S Kickler; J A Lawson; R C McLean; J Jani; G A FitzGerald; J J Rade
Journal:  J Thromb Haemost       Date:  2012-12       Impact factor: 5.824

3.  Differential Impact of Serial Measurement of Nonplatelet Thromboxane Generation on Long-Term Outcome After Cardiac Surgery.

Authors:  Nikolaos Kakouros; Tyler J Gluckman; John V Conte; Thomas S Kickler; Katherine Laws; Bruce A Barton; Jeffrey J Rade
Journal:  J Am Heart Assoc       Date:  2017-11-02       Impact factor: 5.501

4.  Risk Factors for Nonplatelet Thromboxane Generation After Coronary Artery Bypass Graft Surgery.

Authors:  Nikolaos Kakouros; Susanna M Nazarian; Patrizia B Stadler; Thomas S Kickler; Jeffrey J Rade
Journal:  J Am Heart Assoc       Date:  2016-03-15       Impact factor: 5.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.